In the long struggle between human medicine and invisible pathogens, a quiet revolution is unfolding in the intensive care units of London. At Great Ormond Street Hospital, a same-day metagenomic test — one that reads all genetic material in a single sample at once — has begun identifying infections that conventional diagnostics could not find, altering treatment in a quarter of critically ill children studied. Where Victorian-era methods required days and guesswork, this technology offers something closer to certainty, arriving at a moment when antimicrobial resistance makes the cost of a wro
Same-day genetic test detects hidden infections in critically ill children
A 10-year-old girl with pneumonia faced a 50% survival chance and multiple cardiac arrests before metagenomic testing identified her drug-resistant infection, enabling life-saving treatment.
The test identified what doctors had missed. It saved her life.
Mark
So this test sequences everything in a sample at once. How is that faster than culturing bacteria, which I thought was the bottleneck?
Mimi
Culturing takes days because you're waiting for organisms to grow in a lab. Metagenomics is genetic sequencing—it can be done in hours. You get results the same day.
Luke
But does same-day mean the hospital actually acts on it same-day? Or does it sit in a queue?
Mimi
In Willow's case, it clearly changed her treatment quickly enough to matter. The study shows a quarter of the 122 children had prescribing changes based on the results.
Mark
A quarter seems significant but not overwhelming. What about the other three-quarters?
Mimi
Some of them were already on the right treatment. The test confirmed it. Others had no infection, or the infection was already identified by conventional methods. The value isn't just in changing minds—it's in confirming what you're doing is right, and doing it faster.
Luke
The study ran in 2024-25 and results just published. How long was the lag between testing and publication?
Mimi
Several months, which is normal for peer review. But the hospital was using the results clinically in real time during the study.
Mark
What about cost? Is this test expensive?
Luke
The article doesn't say. That's a real gap if we're talking about rolling it out to thirty units.
Mimi
Fair point. But the antimicrobial resistance angle is huge—unnecessary antibiotics drive resistance. If this test prevents even some of that, the economics might work out.
Mark
And the pandemic early warning system—how realistic is that?
Mimi
It's speculative, but the logic is sound. If a new pathogen shows up in a respiratory sample, metagenomics would catch it before culture or PCR would. You'd see the genetic signature.
Luke
But you'd still need someone to recognize it as novel and raise the alarm. The test is only as good as the human response.
O Pulso
- Children arriving in intensive care with unidentified infections face a narrowing window where the wrong antibiotic is not merely ineffective — it can be fatal, as one ten-year-old's multiple cardiac arrests made devastatingly clear.
- Standard diagnostic tools — petri dish cultures and targeted PCR tests — are blind to what they are not already looking for, leaving clinicians to gamble on educated guesses while resistant organisms go unnamed.
- Metagenomic sequencing cuts through that uncertainty in a single day, identifying bacteria, viruses, and fungi simultaneously, and in one study caught fifty pathogens that routine testing missed entirely.
- In roughly a quarter of 122 critically ill children studied, the results directly changed prescriptions — some children received antibiotics they urgently needed, others were spared drugs that were actively harming the fight against resistance.
- The technology is now expanding to approximately thirty UK intensive care units and is being eyed as a potential early-warning system capable of flagging novel pathogens before a new pandemic takes hold.
In the long struggle between human medicine and invisible pathogens, a quiet revolution is unfolding in the intensive care units of London. At Great Ormond Street Hospital, a same-day metagenomic test — one that reads all genetic material in a single sample at once — has begun identifying infections that conventional diagnostics could not find, altering treatment in a quarter of critically ill children studied. Where Victorian-era methods required days and guesswork, this technology offers something closer to certainty, arriving at a moment when antimicrobial resistance makes the cost of a wrong answer ever harder to bear.
When Willow Crowther arrived at Great Ormond Street Hospital in March, her pneumonia had already stopped her heart multiple times. Doctors gave her a fifty-fifty chance of surviving the night, and her mother was asked to gather the family to say goodbye.
Willow survived because of a test most hospitals did not yet possess. Metagenomic testing sequences every piece of genetic material in a sample — bacteria, viruses, fungi — all at once, without requiring clinicians to first suspect what they are looking for. In Willow's case, it revealed that her infection was resistant to the antibiotic she had been given. Once doctors switched to the right drug, she began to recover. Months later, she went home.
Researchers at Great Ormond Street studied the approach systematically, sending respiratory samples from 122 critically ill children for metagenomic analysis between 2024 and 2025. Published this month in the Lancet Microbe, the results showed the test identified roughly nine in ten bacteria and viruses, and caught every fungal infection in the samples. In a quarter of cases, the findings changed what doctors prescribed — some children were started on treatments they needed, others taken off drugs that were not working.
The contrast with older methods is profound. Culturing bacteria in petri dishes, unchanged since the Victorian era, takes days and only works if the organism can be grown in a lab. PCR testing is faster but requires clinicians to already suspect the culprit. Metagenomics removes that guesswork entirely, and in this study caught fifty organisms that routine diagnostics had missed. Dr. Julianne Brown, who leads the hospital's metagenomics service, sees a still larger horizon: the same technology could detect a novel pathogen early enough to contain the next pandemic.
Building on earlier adult trials at Guy's and St Thomas' NHS Trust, the technology is now being rolled out to roughly thirty intensive care units across the UK. For Willow's parents, the arithmetic is simple. Her father calls it a miracle. Her mother calls it what it was: the thing that saved her daughter's life.
A ten-year-old girl from Kent arrived at Great Ormond Street Hospital in March with pneumonia so severe it triggered seizures and stopped her heart multiple times. Doctors told her parents the odds were brutal: fifty-fifty she would survive the night. Her mother, Stacey Moore, remembers being asked to gather the family to say goodbye.
Willow Crowther lived because of a test most hospitals didn't have. It's called metagenomic testing, and it works by sequencing every piece of genetic material in a sample—bacteria, viruses, fungi, everything at once. A doctor doesn't have to guess what infection they're hunting for. The test finds it. In Willow's case, it revealed something conventional tests had missed: her infection was resistant to the antibiotic she'd been given. Once doctors switched her to the right drug, her body began to heal. She spent several more months in the hospital, but she went home.
At Great Ormond Street, researchers studied this approach systematically. Between 2024 and 2025, they sent respiratory samples from 122 critically ill children in the pediatric intensive care unit for metagenomic analysis. The results, published this month in the Lancet Microbe, show the test identified roughly nine in ten bacteria and viruses, and caught every fungal infection in the samples. In a quarter of all cases—about thirty children—the results changed what doctors prescribed. Some were started on antibiotics they needed. Others were taken off drugs that weren't working, a distinction that matters enormously as antibiotic-resistant infections spread.
The contrast with older methods is stark. Culturing bacteria in Petri dishes, the standard since Victorian times, takes days and only works if the organism grows in a lab. PCR testing can identify viruses and some bacteria, but only if clinicians already suspect what they're looking for. Metagenomics removes that guesswork. Dr. Sam Ray, a consultant in pediatric intensive care at the hospital, explains the shift plainly: doctors used to make educated guesses about which infection a child had. Now they can see what's actually there. "Removing unnecessary treatment is incredibly important for the fight against growing antimicrobial resistance," he said.
The test also caught fifty organisms that routine diagnostics missed entirely—pathogens that might have gone undetected and untreated. That capability points toward a larger possibility. Dr. Julianne Brown, who heads the hospital's metagenomics service, notes the technology could serve as an early warning system for new infections that pose pandemic risk. "If there was to be a new mystery pathogen that could be a cause of the next pandemic, we would detect that very quickly and put the right measures in place."
Great Ormond Street's work builds on earlier trials at Guy's and St Thomas' NHS Trust, which first tested the approach on adult patients with respiratory infections. Now the technology is being rolled out gradually across roughly thirty intensive care units throughout the UK, treating both children and adults. For Willow Crowther and her parents, the test's availability was the difference between a funeral and a recovery. Her father, Russ, calls it a miracle. Her mother says simply: "It saved her life."
Citações Notáveis
The test identified that Willow had a drug-resistant bacterial infection which needed a different antibiotic to the one she had been prescribed. The fact that they had a test there available to her was paramount. It saved her life.— Stacey Moore, Willow's mother
The study has helped us to spot infections we would have missed, get children on the right treatment and stop antibiotics when we know they aren't going to work. Removing unnecessary treatment is incredibly important for the fight against growing antimicrobial resistance.— Dr. Sam Ray, consultant in pediatric intensive care at Great Ormond Street Hospital
Quer a matéria completa?
Leia o original em BBC News ↗
Health & Medicine